Medical News

RSS

New study raises hope to successfully fight chytridiomycosis

An international team of researchers has made important progress in understanding the distribution of the deadly amphibian chytrid pathogen. In some regions, the deadly impact of the pathogen appears to be hampered by small predators, naturally occurring in freshwater bodies. These micropredators may efficiently reduce the number of free-swimming infectious stages (zoospores) by consuming them. This natural behavior will reduce the infection pressure on potential amphibian hosts and a goes a long way towards explaining the occurrence of chytridiomycosis, at least in temporal climatic regions.

21 Jan 2014

Levels of depression and anxiety are higher in people with severe rheumatoid arthritis

Levels of depression and anxiety in people with severe rheumatoid arthritis are higher than previously reported, according to new research. As a result of their findings, a multi-centre team led by researchers at the Arthritis Research UK Centre for Genetics and Genomics at the University of Manchester, say that patients with severe active disease, who are waiting to go onto a biological therapy, should be routinely screened for depression by their doctors.

From The University of Manchester 21 Jan 2014

Damon Runyon Cancer Research Foundation awards $2.25M to six innovative young scientists

The Damon Runyon Cancer Research Foundation announced that six scientists with novel approaches to fighting cancer have been named 2014 recipients of the Damon Runyon-Rachleff Innovation Award. The grant of $450,000 over three years is awarded each year to early career scientists whose projects have the potential to significantly impact the prevention, diagnosis and treatment of cancer.

21 Jan 2014

Studies providing mixed news on effects of health law

Separate Rand and McKinsey studies examined how coverage will be affected by cost and accessibility of plans on the exchanges. Also, USA Today looked at the less-explored phenomenon of co-ops.

21 Jan 2014

Irregular sleep timing disrupts daily rhythms of our genes

A new study from the University of Surrey, published today in the journal PNAS (Proceedings of the National Academy of Sciences), found that the daily rhythms of our genes are disrupted when sleep times shift.

21 Jan 2014

University of Liverpool awarded £3.2 million to develop new diagnostic tests for cancers

The University of Liverpool has been awarded -3.2 million to develop new diagnostic tests for cervical, oesophageal and prostate cancer patients.

21 Jan 2014

Study provides new information about life expectancy of people with multiple sclerosis

The first large scale study in the U.S. on the mortality of patients with multiple sclerosis has been published and provides new information about the life expectancy of people with the disease. The study appears in the journal Multiple Sclerosis and Related Disorders.

21 Jan 2014

Sitting for long hours increases heart failure risk in men

Sitting for long periods increases heart failure risk in men, even for those who exercise regularly, according to new research published in the American Heart Association journal Circulation: Heart Failure.

21 Jan 2014

Even as exchange enrollment numbers appear sluggish, Medicaid expansion sign-ups surge in many states

The New York Times also notes that many of these new Medicaid beneficiaries are people who have not had insurance before. Meanwhile, news outlets continue to track developments regarding how governors continue to wrestle with Medicaid decisions -- including those in Virginia, Michigan and Maine. Also in the news, a problem with Maryland's Medicaid enrollment.

21 Jan 2014

Study finds that Mediterranean diet may also prevent peripheral artery disease

A multicenter study that previously reported a reduction in heart attack and stroke with a Mediterranean diet supplemented with extra-virgin olive oil or with nuts now also reports a lower risk of peripheral artery disease, according to a study in the January 22/29 issue of JAMA.

21 Jan 2014

Long term exposure to particulate matter in outdoor air linked to heart attacks and angina

Long term exposure to particulate matter in outdoor air is strongly linked to heart attacks and angina, and this association persists at levels of exposure below the current European limits, suggests research conducted at the Department of Epidemiology in Rome, Italy and published on bmj.com today.

21 Jan 2014

Kolltan Pharmaceuticals announces treatment of first cancer patient with KTN3379

Kolltan Pharmaceuticals, a privately held biopharmaceutical company, today announced treatment of the first cancer patient with Kolltan's lead drug candidate, KTN3379, as part of a Phase 1 clinical study evaluating safety, preliminary evidence of antitumor activity, and pharmacokinetics. KTN3379 is a human monoclonal antibody that blocks the activity of ErbB3, a member of the ErbB family of receptor tyrosine kinases.

21 Jan 2014

Study: Probability of blindness due to glaucoma has decreased by nearly half

The probability of blindness due to the serious eye disease glaucoma has decreased by nearly half since 1980, according to a study published this month in Ophthalmology, the journal of the American Academy of Ophthalmology. The researchers speculate that advances in diagnosis and therapy are likely causes for the decrease, but caution that a significant proportion of patients still progress to blindness.

21 Jan 2014

Vivaldi Biosciences inks agreement with NIAID to evaluate LAIV candidates against influenza A

Vivaldi Biosciences Inc., a clinical-stage biotechnology company developing live attenuated influenza vaccines against seasonal and pandemic influenza, today announced that it has signed a Cooperative Research and Development Agreement with the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to generate and evaluate in preclinical studies LAIV candidates against influenza A(H7N9).

21 Jan 2014

Childhood brain cancer (ETMR/ETANTR): an interview with Dr. Nada Jabado, Department of Pediatrics at McGill University

Embryonal tumours with multilayered rosettes (ETMR) are rare, deadly brain tumours that affect mainly children below the age of 4 years. There are 300 cases reported but probably there are many more as this tumour is often misdiagnosed.

21 Jan 2014

Agenus' Prophage vaccine Phase 2 study hailed in Neuro-Oncology journal

Agenus Inc., a biotechnology company developing novel immune system activating treatments for cancers and infectious diseases, announced that Phase 2 results of Prophage G-200 vaccine in recurrent patients with glioblastoma multiforme were hailed as 'exciting' and a 'very promising therapy' in an editorial published in Neuro-Oncology, the leading journal of the Society of Neuro-Oncology.

21 Jan 2014

HHS to start with beneficiaries backlog in Medicare claims appeals

The Department of Health and Human Services moves to break up a big backlog of Medicare claims appeals, with beneficiary hearings taking precedent. In the meantime, The Fiscal Times looks at overpayment in private Medicare Fee-For-Service plans.

21 Jan 2014

Fluxion Biosciences announces release of IsoFlux Rare Cell Enrichment Kit

Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell and other rare cell capture from biological samples. The IsoFlux Rare Cell Enrichment (Streptavidin) Kit incorporates streptavidin-coated magnetic beads that can bind with one or more biotinylated antibodies targeted towards cell-surface markers on the cells of interest.

From Fluxion Biosciences 21 Jan 2014

HUB Foundation for Organoid Technology signs licensing agreement with STEMCELL Technologies

The HUB Foundation for Organoid Technology announced today that it has signed a licensing agreement with STEMCELL Technologies Inc. for the manufacturing and worldwide distribution of cell culture media for growing Organoids. Organoids are mini-organs grown in tissue culture from small pieces of tissue derived from patients with cancer and other diseases, and represent an exciting new tool for scientific research and drug discovery and validation.

21 Jan 2014

HealthTrust selects BC Technical as provider for refurbished medical imaging equipment

BC Technical, a leading non-OEM medical imaging solutions provider, announced today that it has been selected by HealthTrust as a provider for refurbished medical imaging equipment for the 1,400 acute care facilities that are part of the HealthTrust membership.

21 Jan 2014

Medical News

New study raises hope to successfully fight chytridiomycosis

Levels of depression and anxiety are higher in people with severe rheumatoid arthritis

Damon Runyon Cancer Research Foundation awards $2.25M to six innovative young scientists

Studies providing mixed news on effects of health law

Irregular sleep timing disrupts daily rhythms of our genes

University of Liverpool awarded £3.2 million to develop new diagnostic tests for cancers

Study provides new information about life expectancy of people with multiple sclerosis

Sitting for long hours increases heart failure risk in men

Even as exchange enrollment numbers appear sluggish, Medicaid expansion sign-ups surge in many states

Study finds that Mediterranean diet may also prevent peripheral artery disease

Long term exposure to particulate matter in outdoor air linked to heart attacks and angina

Kolltan Pharmaceuticals announces treatment of first cancer patient with KTN3379

Study: Probability of blindness due to glaucoma has decreased by nearly half

Vivaldi Biosciences inks agreement with NIAID to evaluate LAIV candidates against influenza A

Childhood brain cancer (ETMR/ETANTR): an interview with Dr. Nada Jabado, Department of Pediatrics at McGill University

Agenus' Prophage vaccine Phase 2 study hailed in Neuro-Oncology journal

HHS to start with beneficiaries backlog in Medicare claims appeals

Fluxion Biosciences announces release of IsoFlux Rare Cell Enrichment Kit

HUB Foundation for Organoid Technology signs licensing agreement with STEMCELL Technologies

HealthTrust selects BC Technical as provider for refurbished medical imaging equipment

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Latest News